Published in J Pharmacol Exp Ther on October 27, 2006
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2008) 1.59
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J Pharmacol Exp Ther (2011) 1.37
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol (2013) 1.36
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology (2012) 1.21
Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav (2008) 1.17
Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology (2010) 1.13
Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys. Behav Pharmacol (2011) 1.08
Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology (Berl) (2010) 1.08
Discriminative and reinforcing stimulus effects of nicotine, cocaine, and cocaine + nicotine combinations in rhesus monkeys. Exp Clin Psychopharmacol (2011) 1.08
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev (2015) 1.06
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol (2008) 1.06
Agonist Medications for the Treatment of Cocaine Use Disorder. Neuropsychopharmacology (2014) 1.04
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther (2009) 1.03
Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys. Neuropsychopharmacology (2012) 1.02
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend (2014) 1.01
The encoding of cocaine vs. natural rewards in the striatum of nonhuman primates: categories with different activations. Neuroscience (2009) 1.01
Serotonergic mechanisms in addiction-related memories. Behav Brain Res (2008) 1.01
Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys. Exp Clin Psychopharmacol (2010) 0.99
Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther (2012) 0.98
Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem (2012) 0.97
Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys. Exp Clin Psychopharmacol (2011) 0.92
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys. Exp Clin Psychopharmacol (2014) 0.89
Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacol Rev (2016) 0.87
Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine- and food-maintained responding in rhesus monkeys. Pharmacol Biochem Behav (2008) 0.87
Changes in feeding and locomotion induced by amphetamine analogs in rats. Drug Alcohol Depend (2008) 0.86
Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Adv Pharmacol (2014) 0.84
Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations. Neuropharmacology (2014) 0.83
Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey. Pharmacol Biochem Behav (2009) 0.83
Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys. J Pharmacol Exp Ther (2014) 0.81
Receptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling. ACS Chem Neurosci (2010) 0.81
Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys. Pharmacol Biochem Behav (2015) 0.80
Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys. J Pharmacol Exp Ther (2013) 0.80
A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys. Psychopharmacology (Berl) (2008) 0.80
Differential modulation of cocaine's discriminative cue by repeated and variable stress exposure: relation to monoamine transporter levels. Neuropharmacology (2012) 0.78
Effects of the dopamine/norepinephrine releaser phenmetrazine on cocaine self-administration and cocaine-primed reinstatement in rats. Psychopharmacology (Berl) (2015) 0.78
Methamphetamine Cured my Cocaine Addiction. J Addict Res Ther (2010) 0.78
Cocaine-like discriminative stimulus effects of amphetamine, cathinone, methamphetamine, and their 3,4-methylenedioxy analogs in male rhesus monkeys. Psychopharmacology (Berl) (2016) 0.78
Perinatal lead exposure alters locomotion induced by amphetamine analogs in rats. Life Sci (2011) 0.77
The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue. Neuropharmacology (2015) 0.76
Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys. Psychopharmacology (Berl) (2015) 0.75
Alpha-ethyltryptamines as dual dopamine-serotonin releasers. Bioorg Med Chem Lett (2014) 0.75
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys. Behav Pharmacol (2016) 0.75
Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys. Psychopharmacology (Berl) (2017) 0.75
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability. Neuropsychopharmacology (2017) 0.75
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse (2001) 4.03
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Behavioral studies of sleep patterns in alcoholics during intoxication and withdrawal. J Pharmacol Exp Ther (1970) 2.45
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation (2000) 2.41
Management of cocaine abuse and dependence. N Engl J Med (1996) 2.24
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization. Mol Pharmacol (2006) 2.06
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther (2005) 1.70
Adrenal function and alcoholism. I. Serum cortisol. Psychosom Med (1971) 1.62
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem (2001) 1.54
Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther (1997) 1.52
Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol (2013) 1.47
Buprenorphine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther (1982) 1.46
Hypothesis that mesolimbic dopamine (DA) plays a key role in mediating the reinforcing effects of drugs of abuse as well as the rewarding effects of ingestive behaviors. J Subst Abuse Treat (1994) 1.45
Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA (1996) 1.44
Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. J Nucl Med (1995) 1.43
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation (1999) 1.42
Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay. Synapse (2001) 1.39
Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol (1993) 1.38
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence. J Med Chem (2000) 1.35
Age-related reduction in functional MRI response to photic stimulation. Neurology (1997) 1.34
Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res (1998) 1.32
Behavioral toxicology: a developing discipline. Fed Proc (1975) 1.32
Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther (1998) 1.31
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. J Med Chem (1999) 1.31
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther (1995) 1.30
Buprenorphine suppresses heroin use by heroin addicts. Science (1980) 1.27
Tension pneumothorax: diagnostic and therapeutic pitfalls. Crit Care Med (1993) 1.25
Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther (1999) 1.25
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience (2008) 1.22
Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology (1999) 1.22
Operant analysis of human heroin self-administration and the effects of naltrexone. J Pharmacol Exp Ther (1981) 1.17
Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology (Berl) (1999) 1.17
Cigarette smoking by women: interactions with alcohol use. Psychopharmacology (Berl) (1987) 1.16
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine. J Med Chem (1998) 1.14
Experimentally induced intoxication in alcoholics: a comparison between programed and spontaneous drinking. J Pharmacol Exp Ther (1970) 1.11
Interhemispheric transfer of a discrimination of moving patterns in pigeon. Brain Res (1968) 1.11
Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther (2001) 1.11
Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J Pharmacol Exp Ther (1999) 1.11
Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J Comp Neurol (1987) 1.07
Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med (1995) 1.07
Effects of heroin self-administration on cigarette smoking. Psychopharmacology (Berl) (1980) 1.06
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan. Bioorg Med Chem Lett (2001) 1.06
Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology (1998) 1.06
Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males. J Pharmacol Exp Ther (1977) 1.05
Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl) (2000) 1.05
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo. J Pharmacol Exp Ther (1996) 1.04
Buprenorphine effects on cigarette smoking. Psychopharmacology (Berl) (1985) 1.04
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther (2009) 1.03
Adrenal function and alcoholism. II. Catecholamines. Psychosom Med (1971) 1.02
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications. Synapse (2000) 1.02
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res (1999) 1.02
Experimental analysis of drinking behavior of chronic alcoholics. Ann N Y Acad Sci (1966) 1.01
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse (2000) 1.01
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists. J Med Chem (1998) 1.01
Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology (Berl) (1999) 1.00
Acute alcohol effects on plasma estradiol levels in women. Psychopharmacology (Berl) (1988) 0.99
Interocular generalization: a study of mirror-image reversal following monocular discrimination training in the pigeon. J Exp Anal Behav (1966) 0.99
GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther (1994) 0.99
Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia. Life Sci (1982) 0.98
Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol (2000) 0.98
Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain. Eur J Pharmacol (1981) 0.98
Effect of beta-FNA on opiate receptor binding: preliminary evidence for two types of mu receptors. Eur J Pharmacol (1983) 0.98
Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. Psychopharmacology (Berl) (2000) 0.98
Medical progress. Biologic concomitants of alcoholism. N Engl J Med (1979) 0.97
Drinking patterns during work-contingent and noncontingent alcohol acquisition. Psychosom Med (1972) 0.96
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. J Pharmacol Exp Ther (1996) 0.95
delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole. J Med Chem (1999) 0.95
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists. J Med Chem (1998) 0.95
1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Neuropsychopharmacology (2001) 0.95
Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse. Pharm Acta Helv (2000) 0.94
Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol (2015) 0.94
Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J Neurosci (1997) 0.94
Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther (1996) 0.94
Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use. Psychopharmacology (Berl) (1984) 0.93
Alcoholism and prevalence of medical and psychiatric disorders. J Stud Alcohol (1986) 0.93
Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology (1992) 0.93
Binding surface analysis: an intuitive yet quantitative method for the design and analysis of ligand binding studies. Alcohol Drug Res (1986) 0.93
Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther (1999) 0.92
Mirror-image reversal in pigeons. Science (1965) 0.92
Operant acquisition of marihuana by women. J Pharmacol Exp Ther (1985) 0.92
Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Biol Psychiatry (1998) 0.92
Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology (Berl) (1998) 0.92
Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg Med Chem (2000) 0.92
Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity. Peptides (1994) 0.92
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy. J Med Chem (2001) 0.91
Allosteric coupling between morphine and enkephalin receptors in vitro. Mol Pharmacol (1982) 0.91
Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat. Brain Res (1986) 0.91
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands. Synapse (1999) 0.91
Nitric oxide inhibits [3H]dopamine uptake. Brain Res (1994) 0.91
Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J Nucl Med (1993) 0.91
Chronic alcohol effects on anterior pituitary and ovarian hormones in healthy women. J Pharmacol Exp Ther (1988) 0.91
Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res (1989) 0.90